Mednet Logo

When should proton beam therapy be considered for uveal melanoma?

Are there exclusion criteria?
3 Answers
Mednet Member
Mednet Member
Radiation Oncology · ICON plc
Answered on

When the tumor is identified as COMS large or the patient is not in favor of enucleation, and or plaque therapy is not feasible due to location. Tumors located in the back of the eye and under orbital muscles are difficult to treat with plaque without significant risk to the muscles or nerves. The s...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Radiation Oncology · University of Washington School of Medicine
Answered on

Apart from proton therapy, SRS and SRT have also been shown to yield similar outcomes. SRS and SRT will be invaluable for patients with no or limited access to protons. There are numerous studies in the literature showing efficacy and acceptable toxicities.

References:

Yazici et al. IJROBP 2017

Krema e...

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Radiation Oncology · UCSF Medical Center
Answered on · Updated on
1. Proton/particle therapy can and has been used for all T-stages (COMS small, medium, and large uveal melanoma tumors). There are no particular exclusions based on size, extent, location.

2. 95-98.9% Local control

In meta-analyses, prospective, and retrospective published data, 5y LC has been consi...

Join for free or sign in to see the full answer